Concepedia

John Ronan

JR

Statistics

Publications

13

Citations

1.7K

H-Index

12

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Ionis Pharmaceuticals (United States)

University of Bath

Diabetes Australia

John Ronan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and life sciences.

ORCID

Publications per year

1992–2011

13

Publications

13

Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance

Stacey Conarello, Zhihua Li, John Ronan et al. · Proceedings of the National Academy of Sciences · 2003 · 350 citations · Full text

, , +17

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1

Guoqiang Jiang, Zhihua Li, Franklin Liu et al. · Journal of Clinical Investigation · 2005 · 256 citations · Full text

, , +17

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1

Guoqiang Jiang, Zhihua Li, Franklin Liu et al. · Journal of Clinical Investigation · 2005 · 237 citations

, , +17

Impaired Wound Contraction in Stromelysin-1–Deficient Mice

Kelli M. Bullard, Leif R. Lund, John S. Mudgett et al. · Annals of Surgery · 1999 · 233 citations

, , +16

Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia

Stacey Conarello, Guoqiang Jiang, James Mu et al. · Diabetologia · 2006 · 219 citations · Full text

, , +16

1–5 of 13